๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT ยท Real-Time Price ยท USD
1.810
-0.050 (-2.69%)
At close: Nov 20, 2026, 4:00 PM EST
1.840
+0.030 (1.66%)
After-hours: Nov 20, 2026, 5:33 PM EST

BBOT Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Income
-187.26-145.82-80.86-64.77
Net Income
-171.53-134.04-74.28-64.7
Earnings Per Share
-2.14-4.30-5756.41-518.73
EPS Growth
----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Cash & Investments
315.33425.46155.630.25
Total Debt
2.382.77--
Net Cash (Debt)
312.95422.69155.630.25
Net Cash Growth
-32.76%171.60%62152.40%-
Net Cash Per Share
3.9013.5712061.612.00

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-150.88-113.89-55.03-52.08
Capital Expenditures
-0.16-0.61-0.05-0.41
Free Cash Flow
-151.03-114.5-55.08-52.49
Free Cash Flow Growth
----

Valuation

Selected indicators aren't available for this stock.